6,500
Views
58
CrossRef citations to date
0
Altmetric
Review

COVID-19: fighting the invisible enemy with microRNAs

, , & ORCID Icon
Pages 137-145 | Received 22 Jun 2020, Accepted 14 Aug 2020, Published online: 16 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ceren Eyileten, Zofia Wicik, Sérgio N. Simões, David C. Martins-Jr, Krzysztof Klos, Wojciech Wlodarczyk, Alice Assinger, Dariusz Soldacki, Andrzej Chcialowski, Jolanta M. Siller-Matula & Marek Postula. (2022) Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19. RNA Biology 19:1, pages 963-979.
Read now
Sumadee De Silva, Kamani Hemamala Tennekoon & Eric Hamilton Karunanayake. (2021) Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity. OncoTargets and Therapy 14, pages 5115-5129.
Read now

Articles from other publishers (56)

Debabrata Ghosh Dastidar, Dipanjan Ghosh, Swarnasree Ghosh & Gopal Chakrabarti. (2023) Current Therapeutic Strategies and Possible Effective Drug Delivery Strategies against COVID-19. Current Drug Delivery 20:10, pages 1441-1464.
Crossref
Olfat Shaker, Monica El Amir, Yasmine Abd Elfatah & Heba M. Elwi. (2023) Expression patterns of lncRNA MALAT-1 in SARS-COV-2 infection and its potential effect on disease severity via miR-200c-3p and SIRT1. Biochemistry and Biophysics Reports 36, pages 101562.
Crossref
Yuhao Lin, Qiqi Sun, Bao Zhang, Wei Zhao & Chenguang Shen. (2023) The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection. Frontiers in Cell and Developmental Biology 11.
Crossref
Irina Gilyazova, Yanina Timasheva, Alexandra Karunas, Anastasiya Kazantseva, Albert Sufianov, Andrey Mashkin, Gulnaz Korytina, Yaolou Wang, Ilgiz Gareev & Elza Khusnutdinova. (2023) COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments. Non-coding RNA Research 8:2, pages 240-254.
Crossref
Xu Xin, Yu Jia-Yin, Huang Jun-Yang, Wang Rui, Kuang Xiong-Ri, Dang Long-Rui, Jie Liu & Zhou Jue-Yu. (2023) Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis. Computers in Biology and Medicine 159, pages 106943.
Crossref
Yaping He, Daifeng Li, Li Wu, Xianzhen Yin, Xiaojian Zhang, Laurence H. Patterson & Jiwen Zhang. (2023) Metal‐Organic Frameworks for Gene Therapy and Detection. Advanced Functional Materials 33:12, pages 2212277.
Crossref
Vikas Yadav & Srividhya Ravichandran. (2023) Significance of understanding the genomics of host–pathogen interaction in limiting antibiotic resistance development: lessons from COVID-19 pandemic. Briefings in Functional Genomics.
Crossref
Carmine Izzo, Valeria Visco, Jessica Gambardella, Germano Junior Ferruzzi, Antonella Rispoli, Maria Rosaria Rusciano, Anna Laura Toni, Nicola Virtuoso, Albino Carrizzo, Paola Di Pietro, Guido Iaccarino, Carmine Vecchione & Michele Ciccarelli. (2023) Cardiovascular Implications of microRNAs in Coronavirus Disease 2019. Journal of Pharmacology and Experimental Therapeutics 384:1, pages 102-108.
Crossref
Md Arju Hossain, Md Sohel, Tayeba Sultana, Md Imran Hasan, Md Sharif Khan, K.M. Kaderi Kibria, S.M. Hasan Mahmud & Md Habibur Rahman. (2023) Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology. Informatics in Medicine Unlocked 40, pages 101289.
Crossref
Bineypreet Kaur & Jaspreet Kaur. 2023. Omics approaches and technologies in COVID-19. Omics approaches and technologies in COVID-19 145 160 .
Omid Gholizadeh, Sama Akbarzadeh, Zahra Yekanipour, Raheleh Tabatabaie, Somayeh Sedighi & Hamed Afkhami. (2022) Molecular Mechanisms of Non-Coding RNAs in Modulating the Pathogenesis of SARS-Cov-2 Infection. The Open COVID Journal 2:1.
Crossref
Jacques Demongeot & Cécile Fougère. (2022) mRNA COVID-19 Vaccines—Facts and Hypotheses on Fragmentation and Encapsulation. Vaccines 11:1, pages 40.
Crossref
Gabriel Araujo Tavares, Amada Torres, Gwenola Le Drean, Maïwenn Queignec, Blandine Castellano, Laurent Tesson, Séverine Remy, Ignacio Anegon, Bruno Pitard & Bertrand Kaeffer. (2022) Oral Delivery of miR-320-3p with Lipidic Aminoglycoside Derivatives at Mid-Lactation Alters miR-320-3p Endogenous Levels in the Gut and Brain of Adult Rats According to Early or Regular Weaning. International Journal of Molecular Sciences 24:1, pages 191.
Crossref
Indrajit Saha, Nimisha Ghosh & Dariusz Plewczynski. (2022) Identification of Human miRNA Biomarkers Targeting the SARS-CoV-2 Genome. ACS Omega 7:50, pages 46411-46420.
Crossref
Leyla Tahrani Hardin & Nan Xiao. (2022) miRNAs: The Key Regulator of COVID-19 Disease. International Journal of Cell Biology 2022, pages 1-19.
Crossref
Lin Liu, Yao Zhang, Yu Chen, Yueshui Zhao, Jing Shen, Xu Wu, Mingxing Li, Meijuan Chen, Xiaobing Li, Yuhong Sun, Li Gu, Wanping Li, Fang Wang, Lei Yao, Zhuo Zhang, Zhangang Xiao & Fukuan Du. (2022) Therapeutic prospects of ceRNAs in COVID-19. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Hong-Yu Liang, Yuyan Wu, Vicky Yau, Huan-Xin Yin, Scott Lowe, Rachel Bentley, Mubashir Ayaz Ahmed, Wenjing Zhao & Chenyu Sun. (2022) SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19. Vaccines 10:9, pages 1538.
Crossref
Mamta Panda, Elora Kalita, Satyendra Singh, Ketan Kumar, Abhishek Rao & Vijay Kumar Prajapati. (2022) MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies. Life Sciences 305, pages 120761.
Crossref
Yiran E. Li, Amir Ajoolabady, Muralikrishnan Dhanasekaran & Jun Ren. (2022) Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy. Pharmacological Research 182, pages 106334.
Crossref
Marselina Irasonia Tan, Nayla Majeda Alfarafisa, Popi Septiani, Anggraini Barlian, Mochamad Firmansyah, Ahmad Faizal, Lili Melani & Husna Nugrahapraja. (2022) Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19. Cells 11:15, pages 2319.
Crossref
Ly Hien Doan, Li-Wei Chu, Zi-Yi Huang, Anh Thuc Nguyen, Chia-Yin Lee, Chien-Ling Huang, Yu-Fen Chang, Wen-Yu Hsieh, Trang Thi Huyen Nguyen, Chao-Hsiung Lin, Chun-Li Su, Tsung-Hsien Chuang, Jin-Mei Lai, Feng-Sheng Wang, Chia-Jui Yang, Hui-Kang Liu, Yueh-Hsin Ping & Chi-Ying F. Huang. (2022) Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2. Frontiers in Pharmacology 13.
Crossref
Saba Zanganeh, Nima Goodarzi, Mohammad Doroudian & Elaheh Movahed. (2021) Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated review. Reviews in Medical Virology 32:4.
Crossref
Haibo Xu, Xiaowen Hu, Xiaoguang Yan, Wei Zhong, Dongsheng Yin & Yunfeng Gai. (2022) Exploring noncoding RNAs in thyroid cancer using a graph convolutional network approach. Computers in Biology and Medicine 145, pages 105447.
Crossref
Nadia M. Hamdy, Fatma H. Shaker, Xianquan Zhan & Emad B. Basalious. (2022) Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?. EPMA Journal 13:2, pages 261-284.
Crossref
Qiqi Zeng, Xin Qi, Junpeng Ma, Fang Hu, Xiaorui Wang, Hongyu Qin, Mengyang Li, Shaoxin Huang, Yong Yang, Yixin Li, Han Bai, Meng Jiang, Doudou Ren, Ye Kang, Yang Zhao, Xiaobei Chen, Xi Ding, Di Ye, Yankui Wang, Jianguo Jiang, Dong Li, Xi Chen, Ke Hu, Binghong Zhang, Bingyin Shi & Chengsheng Zhang. (2022) Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection. iScience 25:5, pages 104309.
Crossref
Kayode Oshinubi, Cécile Fougère & Jacques Demongeot. (2022) A Model for the Lifespan Loss Due to a Viral Disease: Example of the COVID-19 Outbreak. Infectious Disease Reports 14:3, pages 321-340.
Crossref
Asim Azhar, Wajihul Hasan Khan, Khaled Al-Hosaini & Mohammad Amjad Kamal. (2022) miRNAs in SARS-CoV-2 Infection: An Update. Current Drug Metabolism 23:4, pages 283-298.
Crossref
Atiyabanu N. Saiyed, Abhay R. Vasavada & S. R. Kaid Johar. (2022) Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, Khaled Alhosaini, Mohammad Owais & Aijaz Ahmad. (2022) Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach. Journal of Infection and Public Health 15:4, pages 466-479.
Crossref
Ales Eichmeier, Tomas Kiss, Maria Kocanova, Eliska Hakalova, Milan Spetik, Jana Cechova & Boris Tichy. (2022) Conserved MicroRNAs in Human Nasopharynx Tissue Samples from Swabs Are Differentially Expressed in Response to SARS-CoV-2. Genes 13:2, pages 348.
Crossref
Evgenii Gusev, Alexey Sarapultsev, Liliya Solomatina & Valeriy Chereshnev. (2022) SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. International Journal of Molecular Sciences 23:3, pages 1716.
Crossref
Jyothsna Manikkath, Padacherri Vethil Jishnu, Peter R Wich, Aparna Manikkath & Raghu Radhakrishnan. (2022) Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine 17:3, pages 181-195.
Crossref
Riham Abdel-Hamid Haroun, Waleed H. Osman, Rasha E. Amin, Ahmad K. Hassan, Waleed S. Abo-Shanab & Asmaa M. Eessa. (2022) Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection. Pathology 54:1, pages 104-110.
Crossref
Xiao-wen Cheng, Jie Li, Lu Zhang, Wen-jun Hu, Lu Zong, Xiang Xu, Jin-ping Qiao, Mei-juan Zheng, Xi-wen Jiang, Zhi-kun Liang, Yi-fan Zhou, Ning Zhang, Hua-qing Zhu & Yuan-hong Xu. (2022) Identification of SARS-CoV-2 Variants and Their Clinical Significance in Hefei, China. Frontiers in Medicine 8.
Crossref
Xiaolan Wu, Shanshan Jin, Chengye Ding, Yu Wang, Danqing He & Yan Liu. (2022) Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed. Frontiers in Microbiology 12.
Crossref
Brandon Bautista-Becerril, Guillermo Pérez-Dimas, Paola C. Sommerhalder-Nava, Alejandro Hanono, Julio A. Martínez-Cisneros, Bárbara Zarate-Maldonado, Evangelina Muñoz-Soria, Arnoldo Aquino-Gálvez, Manuel Castillejos-López, Armida Juárez-Cisneros, Jose S. Lopez-Gonzalez & Angel Camarena. (2021) miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19. Viruses 14:1, pages 41.
Crossref
Periklis Katopodis, Harpal S. Randeva, Demetrios A. Spandidos, Sayeh Saravi, Ioannis Kyrou & Emmanouil Karteris. (2021) Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review). International Journal of Molecular Medicine 49:2.
Crossref
Jessica Gasparello, Elisabetta d'Aversa, Giulia Breveglieri, Monica Borgatti, Alessia Finotti & Roberto Gambari. (2021) In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR. International Immunopharmacology 101, pages 108201.
Crossref
Nahid Arghiani, Tracy Nissan & Maryam M. Matin. (2021) Role of microRNAs in COVID-19 with implications for therapeutics. Biomedicine & Pharmacotherapy 144, pages 112247.
Crossref
Bruno Fattizzo, Raffaella Pasquale, Valentina Bellani, Wilma Barcellini & Austin G. Kulasekararaj. (2021) Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature. Frontiers in Immunology 12.
Crossref
Mohammed M. Almutairi, Farzane Sivandzade, Thamer H. Albekairi, Faleh Alqahtani & Luca Cucullo. (2021) Neuroinflammation and Its Impact on the Pathogenesis of COVID-19. Frontiers in Medicine 8.
Crossref
Sara H. A. Agwa, Hesham Elghazaly, Mahmoud Shawky El Meteini, Sherif M. Shawky, Marwa Ali, Aya M. Abd Elsamee, Safa Matbouly Sayed, Nadine Sherif, Howida M. Sharaf, Mohamed A. Alhadidy & Marwa Matboli. (2021) In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity. Cells 10:11, pages 3098.
Crossref
Giulia Bivona, Luisa Agnello & Marcello Ciaccio. (2021) Biomarkers for Prognosis and Treatment Response in COVID-19 Patients. Annals of Laboratory Medicine 41:6, pages 540-548.
Crossref
Zeinab Amini-Farsani, Mahtab Yadollahi-Farsani, Samaneh Arab, Fatemeh Forouzanfar, Mitra Yadollahi & Samira Asgharzade. (2021) Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways. International Immunopharmacology 100, pages 108071.
Crossref
Hao Ying, Mohsen Ebrahimi, Mona Keivan, Seyed Esmaeil Khoshnam, Sarvenaz Salahi & Maryam Farzaneh. (2021) miRNAs; a novel strategy for the treatment of COVID‐19. Cell Biology International 45:10, pages 2045-2053.
Crossref
Kimia Kardani, Azam Bolhassani, Mona Kardani & Elnaz Agi. (2021) Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. Journal of Medical Microbiology and Infectious Diseases 9:3, pages 122-132.
Crossref
Ghasem Rezanejade Bardajee, Mohammadreza Zamani & Mahdieh Sharifi. (2021) Efficient and Versatile Application of Fluorescence DNA-Conjugated CdTe Quantum Dots Nanoprobe for Detection of a Specific Target DNA of SARS Cov-2 Virus. Langmuir 37:33, pages 10223-10232.
Crossref
Maria Narożna & Błażej Rubiś. (2021) Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. International Journal of Molecular Sciences 22:16, pages 8663.
Crossref
Swayam Prakash Srivastava, Rohit Srivastava, Subhash Chand & Julie E. Goodwin. (2021) Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease. Pharmaceuticals 14:8, pages 751.
Crossref
María Asunción Barreda-Manso, Manuel Nieto-Díaz, Altea Soto, Teresa Muñoz-Galdeano, David Reigada & Rodrigo M. Maza. (2021) In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3′-UTR. International Journal of Molecular Sciences 22:11, pages 6094.
Crossref
Dan Li, Jianhui Yang, Yong Yang, Jianxin Liu, Hui Li, Rongfei Li, Chunya Cao, Liping Shi, Weihua Wu & Kai He. (2021) A Timely Review of Cross-Kingdom Regulation of Plant-Derived MicroRNAs. Frontiers in Genetics 12.
Crossref
Mona Fani, Milad Zandi, Saeedeh Ebrahimi, Saber Soltani & Samaneh Abbasi. (2021) The role of miRNAs in COVID-19 disease. Future Virology 16:4, pages 301-306.
Crossref
Iago Carvalho Schultz, Ana Paula Santin Bertoni & Márcia Rosângela Wink. (2021) Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis. Stem Cell Reviews and Reports 17:2, pages 341-356.
Crossref
Manijeh Mohammadi-Dehcheshmeh, Sadrollah Molaei Moghbeli, Samira Rahimirad, Ibrahim O. Alanazi, Zafer Saad Al Shehri & Esmaeil Ebrahimie. (2021) A Transcription Regulatory Sequence in the 5′ Untranslated Region of SARS-CoV-2 Is Vital for Virus Replication with an Altered Evolutionary Pattern against Human Inhibitory MicroRNAs. Cells 10:2, pages 319.
Crossref
Mohammed Sikander, Shabnam Malik, Anyssa Rodriguez, Murali M. Yallapu, Acharan S. Narula, Sanjaya K. Satapathy, Vijian Dhevan, Subhash C. Chauhan & Meena Jaggi. (2020) Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules 25:24, pages 5905.
Crossref
S. Greco, A. Madè, C. Gaetano, Y. Devaux, C. Emanueli & F. Martelli. (2020) Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era. Journal of Translational Medicine 18:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.